Aug 6, 2026 08:00AM
Aug 6, 2026 08:00AM
Aug 3, 2026 08:02AM
Aug 3, 2026 08:02AM
Jul 30, 2026 08:30AM
Jul 30, 2026 08:30AM
Jul 28, 2026 07:47AM Clearmind completes Part A of Phase I/II trial for alcohol disorder drug
Jul 28, 2026 07:47AM
Jul 20, 2026 07:55AM
Jul 20, 2026 07:55AM
Jul 17, 2026 07:32AM
Jul 17, 2026 07:32AM
Jul 16, 2026 09:30AM
Jul 16, 2026 09:30AM Clearmind Medicine Reports Positive Retention Results for Intranasal Formulation of its Psychedelic-Based Neuroplastogen MEAI
Jul 13, 2026 08:17AM
Jul 13, 2026 08:17AM
Jul 10, 2026 08:32AM
Jul 10, 2026 08:32AM
Jul 7, 2026 07:43AM
Jul 7, 2026 07:42AM
Jun 29, 2026 07:55AM Clearmind Medicine receives new U.S. patent for binge behavior treatments
Jun 29, 2026 07:55AM
Jun 22, 2026 08:07AM
Jun 22, 2026 08:07AM
Jun 18, 2026 07:55AM
Jun 18, 2026 07:55AM
Jun 16, 2026 07:32AM
Jun 16, 2026 07:32AM Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial
Jun 16, 2026 07:32AM
Jun 5, 2026 07:32AM
May 29, 2026 08:41AM
May 29, 2026 08:32AM
May 26, 2026 08:25AM
May 26, 2026 08:25AM
May 19, 2026 06:00AM Clearmind Medicine announces 1-for-10 reverse stock split effective May 21
May 19, 2026 06:00AM
May 18, 2026 08:42AM
May 18, 2026 08:42AM
May 15, 2026 08:35AM
May 12, 2026 08:41AM
May 12, 2026 08:41AM
May 11, 2026 07:55AM Clearmind Medicine Announces “Inside MEAI” Webinar Featuring New Insights from CMND-100 Psychedelic Clinical Trial
May 5, 2026 08:53AM
May 5, 2026 08:50AM
Apr 27, 2026 07:41AM
Apr 27, 2026 07:41AM
Apr 20, 2026 04:03PM
Apr 20, 2026 04:03PM
Apr 20, 2026 07:15AM Clearmind Medicine meets safety endpoint in alcohol disorder trial
Apr 20, 2026 07:15AM

1,177,149 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All